Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

Glutamate transport asymmetry in renal glutamine metabolism

View through CrossRef
d-Glutamate (Glu) was previously shown to block l-Glu uptake and accelerate glutaminase flux in cultured kidney cells [Welbourne, T. C., and D. Chevalier. Am. J. Physiol. 272 ( Endocrinol. Metab. 35): E367–E370, 1997]. To test whether d-Glu would be taken up by the intact functioning kidney and effect the same response in vivo, male Sprague-Dawley rats were infused withd-Glu (2.6 μmol/min), and renal uptake of d- andl-Glu was determined from chemical and radiolabeled arteriovenous Glu concentration differences times renal plasma flow. The amount removed was then compared with that amount filtered to obtain the antiluminal contribution. In the controls, l-Glu uptake measured as net removal was 33% of the arteriall-Glu load and not different from that filtered, 27%; however, the unidirectional uptake was actually 58% of the arterial load, indicating that antiluminal uptake contributes at least half to the overall Glu consumption. Surprisingly, the kidneys showed a more avid removal ofd-Glu, removing 73% of the arterial load, indicating uptake predominantly across the antiluminal cell surface. Furthermore, uptake ofd-Glu was associated with a 55% reduction in l-Glu uptake, with the residual amount taken up equivalent to that filtered;d-Glu did not increase the excretion of the l-isomer. However, elevating plasma l-Glu concentration reduced uptake of thed-isomer, suggesting a shared antiluminal transporter. Thus there is an apparent asymmetrical distribution of the d-Glu transporter. Under these conditions, kidney cortexl-Glu content decreased 44%, whereas net glutamine (Gln) uptake increased sevenfold (170 ± 89 to 1,311 ± 219 nmol/min, P < 0.01) and unidirectional uptake nearly threefold (393 ± 121 to 1,168 ± 161 nmol/min, P < 0.05); this large Gln consumption was paralleled by an increase in ammonium production so that the ratio of production to consumption approaches 2, consistent with accelerated Gln deamidation and subsequent Glu deamination. These results point to a functional asymmetry (antiluminal vs. luminal) for Glu transporter activity, which potentially plays an important role in modulating Gln metabolism and renal function.
Title: Glutamate transport asymmetry in renal glutamine metabolism
Description:
d-Glutamate (Glu) was previously shown to block l-Glu uptake and accelerate glutaminase flux in cultured kidney cells [Welbourne, T.
C.
, and D.
Chevalier.
Am.
J.
Physiol.
272 ( Endocrinol.
Metab.
35): E367–E370, 1997].
To test whether d-Glu would be taken up by the intact functioning kidney and effect the same response in vivo, male Sprague-Dawley rats were infused withd-Glu (2.
6 μmol/min), and renal uptake of d- andl-Glu was determined from chemical and radiolabeled arteriovenous Glu concentration differences times renal plasma flow.
The amount removed was then compared with that amount filtered to obtain the antiluminal contribution.
In the controls, l-Glu uptake measured as net removal was 33% of the arteriall-Glu load and not different from that filtered, 27%; however, the unidirectional uptake was actually 58% of the arterial load, indicating that antiluminal uptake contributes at least half to the overall Glu consumption.
Surprisingly, the kidneys showed a more avid removal ofd-Glu, removing 73% of the arterial load, indicating uptake predominantly across the antiluminal cell surface.
Furthermore, uptake ofd-Glu was associated with a 55% reduction in l-Glu uptake, with the residual amount taken up equivalent to that filtered;d-Glu did not increase the excretion of the l-isomer.
However, elevating plasma l-Glu concentration reduced uptake of thed-isomer, suggesting a shared antiluminal transporter.
Thus there is an apparent asymmetrical distribution of the d-Glu transporter.
Under these conditions, kidney cortexl-Glu content decreased 44%, whereas net glutamine (Gln) uptake increased sevenfold (170 ± 89 to 1,311 ± 219 nmol/min, P < 0.
01) and unidirectional uptake nearly threefold (393 ± 121 to 1,168 ± 161 nmol/min, P < 0.
05); this large Gln consumption was paralleled by an increase in ammonium production so that the ratio of production to consumption approaches 2, consistent with accelerated Gln deamidation and subsequent Glu deamination.
These results point to a functional asymmetry (antiluminal vs.
luminal) for Glu transporter activity, which potentially plays an important role in modulating Gln metabolism and renal function.

Related Results

Abstract 5473: Identification of compensatory pathway for glutamate production upon glutaminase 1 inhibition
Abstract 5473: Identification of compensatory pathway for glutamate production upon glutaminase 1 inhibition
Abstract Rationale and objectives: A current clinical trial is testing a drug inhibitor for glutaminase 1 (GLS1), the enzyme responsible for glutamine's conversion i...
Étude du métabolisme de la glutamine dans les leucémies aiguës myéloïdes
Étude du métabolisme de la glutamine dans les leucémies aiguës myéloïdes
La survie des cellules cancéreuses dépend d’une activité énergétique et biosynthétique accrue et la glutamine participe à de nombreux processus nécessaires à cette adaptation métab...
Abstract 1872: Targeting MYC-driven medulloblastoma using inhibitors of glutamine metabolism.
Abstract 1872: Targeting MYC-driven medulloblastoma using inhibitors of glutamine metabolism.
Abstract Medulloblastoma is the most common malignant brain tumor in children. Currently, treatment consists of surgical resection, chemotherapy, and whole brain and...
Distribution of Glutaminase and Glutamine Synthetase Activities in the Human Gastrointestinal Tract
Distribution of Glutaminase and Glutamine Synthetase Activities in the Human Gastrointestinal Tract
1. The activities of the two key enzymes involved in glutamine metabolism, glutaminase and glutamine synthetase, were measured in mucosal biopsies taken from different sites throug...
Glutamine availability regulates cDC subsets in tissue
Glutamine availability regulates cDC subsets in tissue
Abstract Proliferating tumor cells take up glutamine for anabolic processes engendering glutamine deficiency in the tumor microenvironment. How thi...
Abstract 3090: Targeting glutamine metabolism as a therapeutic strategy in MYC-driven medulloblastoma
Abstract 3090: Targeting glutamine metabolism as a therapeutic strategy in MYC-driven medulloblastoma
Abstract Medulloblastoma (MB) is the most common malignant pediatric brain tumor. Currently, treatment consists of surgical resection, chemotherapy, craniospinal rad...
RHOJ Derived Peptide Promotes Chemosensitivity by Inhibiting Glutamine Metabolism in Gastric Cancer
RHOJ Derived Peptide Promotes Chemosensitivity by Inhibiting Glutamine Metabolism in Gastric Cancer
Abstract Background Chemoresistance is a cause of the failure of chemotherapy in gastric cancer (GC) treatment. Recent studies ...
Abstract 985: Mitochondrial glutamine fermentation enhances ATP synthesis in murine glioblastoma cells
Abstract 985: Mitochondrial glutamine fermentation enhances ATP synthesis in murine glioblastoma cells
Abstract Otto Warburg first proposed that all cancer cells arise from irreversible impairment of respiration, thus requiring glucose fermentation as a compensatory e...

Back to Top